These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2837244)

  • 1. Norfloxacin resistance in Providencia stuartii: modifications in DNA-gyrase and permeability.
    Landini P; Pagani L; Cereda PM; Debiaggi M; Romero E
    Biochem Pharmacol; 1988 May; 37(9):1855-6. PubMed ID: 2837244
    [No Abstract]   [Full Text] [Related]  

  • 2. Modifications of DNA-gyrase and of permeability in a norfloxacin-resistant clinical isolate of Providencia stuartii.
    Landini P; Pagani L; Debiaggi L; Cereda PM; Romero E
    Microbiologica; 1987 Oct; 10(4):403-11. PubMed ID: 2826973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of norfloxacin inhibition of DNA gyrase induced by a 28 KDal DNA binding protein.
    Landini P; Pagani L; Debiaggi M; Cereda PM; Romero E
    Microbiologica; 1989 Jul; 12(3):247-55. PubMed ID: 2550742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kanamycin resistance in Providencia stuartii.
    McHale P; English L; Speekenbrink A; Keane C
    J Antimicrob Chemother; 1978 May; 4(3):273-8. PubMed ID: 670120
    [No Abstract]   [Full Text] [Related]  

  • 5. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

  • 6. Inducible expression of an aminoglycoside-acetylating enzyme in Providencia stuartii.
    Swiatlo E; Kocka FE
    J Antimicrob Chemother; 1987 Jan; 19(1):27-30. PubMed ID: 3549668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.
    Hooper DC; Wolfson JS; Souza KS; Tung C; McHugh GL; Swartz MN
    Antimicrob Agents Chemother; 1986 Apr; 29(4):639-44. PubMed ID: 3010850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorhexidine resistance and the lipids of Providencia stuartii.
    Thomas B; Stickler DJ
    Microbios; 1979; 24(97-98):141-50. PubMed ID: 530092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance in Providencia stuartii isolated in hospitals.
    McHale PJ; Keane CT; Dougan G
    J Clin Microbiol; 1981 Jun; 13(6):1099-104. PubMed ID: 7251830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory investigation of a suspected outbreak caused by Providencia stuartii with intermediate resistance to imipenem at a long-term care facility.
    Mao YC; Chang CL; Huang YC; Su LH; Lee CT
    J Microbiol Immunol Infect; 2018 Apr; 51(2):214-219. PubMed ID: 27553450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of Providencia stuartii to chlorhexidine: a consideration of the role of the inner membrane.
    Ismaeel N; el-Moug T; Furr JR; Russell AD
    J Appl Bacteriol; 1986 Apr; 60(4):361-7. PubMed ID: 3087933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiseptic-induced changes in the cell surface of a chlorhexidine-sensitive and a chlorhexidine-resistant strain of Providencia stuartii.
    el Moug T; Rogers DT; Furr JR; el-Falaha BM; Russell AD
    J Antimicrob Chemother; 1985 Dec; 16(6):685-9. PubMed ID: 4093343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Providencia stuartii cell envelope enzymes by chlorhexidine.
    Chopra I; Johnson SC; Bennett PM
    J Antimicrob Chemother; 1987 Jun; 19(6):743-51. PubMed ID: 2956230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological studies of increasing appearances of Proteus inconstans (Providencia stuartii) infections (author's transl)].
    Kopf PO; Freitag V; Caselitz FH; Kolbe S
    Immun Infekt; 1980; 8(3):96-100. PubMed ID: 7461700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of urine-grown cells of Providencia stuartii to antiseptics.
    Thomas B; Sykes L; Stickler DJ
    J Clin Pathol; 1978 Oct; 31(10):929-32. PubMed ID: 711901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the bisbiguanides chlorhexidine and alexidine with phospholipid vesicles: evidence for separate modes of action.
    Chawner JA; Gilbert P
    J Appl Bacteriol; 1989 Mar; 66(3):253-8. PubMed ID: 2663802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.
    Ducan IB; Penner JL
    Can Med Assoc J; 1975 Jul; 113(1):29-31. PubMed ID: 807310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation in DNA gyrase of norfloxacin-resistant clinical isolates of Neisseria gonorrhoeae.
    Tanaka M; Otsuki M; Nishino T; Kobayashi I; Matsumoto T; Kumazawa J
    Genitourin Med; 1996 Aug; 72(4):295-7. PubMed ID: 8976839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.